`Tel: 571-272-7822
`
`Paper No. 21
`Entered: August 7, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`BASF SE,
`Petitioner,
`
`v.
`
`FRESENIUS MEDICAL CARE HOLDINGS, INC.,
`Patent Owner.
`____________
`
`Case IPR2017-01948
`Patent 9,353,220 B2
`____________
`
`
`
`
`Before JO-ANNE M. KOKOSKI, CHRISTOPHER M. KAISER, and
`JEFFREY W. ABRAHAM, Administrative Patent Judges.
`
`ABRAHAM, Administrative Patent Judge.
`
`ORDER
`Termination of the Proceedings
`35 U.S.C. § 317(a) and 37 C.F.R. § 42.72
`
`
`
`Case IPR2017-01948
`Patent 9,353,220 B2
`
`
`On July 26, 2018, pursuant to 35 U.S.C. § 317(a), the parties filed a
`
`Joint Motion to Terminate this proceeding. Paper 19. Accompanying the
`
`Motion, the parties filed what they indicate is a true copy of a settlement
`
`agreement along with a Joint Request to treat the settlement agreement as
`
`confidential, to be kept separate from the patent file under 35 U.S.C.
`
`§ 317(b) and 37 C.F.R. § 42.74. Paper 20; Ex. 2003. We authorized the
`
`filing of these papers in an email sent on July 24, 2018.
`
`
`
`We entered a Decision to Institute an inter partes review in this case
`
`on March 12, 2018. Paper 13. Patent Owner has not yet filed its Patent
`
`Owner Response. Based on these facts, it is appropriate to terminate the
`
`proceedings. Thus, the Joint Motion to Terminate the proceeding is granted.
`
`
`
`
`
`Accordingly, it is
`
`ORDERED that the parties’ Joint Motion to Terminate the proceeding
`
`is granted;
`
`
`
`FURTHER ORDERED that the parties’ Joint Request that the
`
`settlement agreement be treated as business confidential information, to be
`
`kept separate from the patent file, is granted; and
`
`
`
`FURTHER ORDERED that the proceeding is terminated.
`
`
`
`2
`
`
`
`Case IPR2017-01948
`Patent 9,353,220 B2
`
`PETITIONER:
`
`Greg Gardella
`ggardella@gardellagrace.com
`
`Eric Myers
`em@gandmpatent.com
`
`Kirsten Gruneberg
`kg@gandmpatent.com
`
`
`PATENT OWNER:
`
`Thomas Engellenner
`engellenner@pepperlaw.com
`
`Reza Mollaaghababa
`mollaaghababa@pepperlaw.com
`
`Andrew Schultz
`schultza@pepperlaw.com
`
`
`
`
`
`3
`
`